Niner Pharmaceuticals LLC is a pharmaceutical firm based in the United Arab Emirates that makes and distributes high-quality pharmaceuticals. Niner Pharmaceuticals LLC seeks to produce world-class pharmaceutical products by manufacturing products that meet WHO, GMP, and Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation (PIC/S) quality requirements. By providing the greatest products at reasonable rates, the company hopes to contribute to a healthier and happier society.
Niner Pharmaceuticals LLC, as a leading maker of pharmaceutical formulations in Liquid Injection, Powder Injection, Tablet, Bolus, Oral Powder, Oral Liquid, Aerosol External Preparation, and Ointment, seeks to not only expand its business scale but also to meet the needs of end consumers.
Mr. Balaji, Chairman and Founder of Niner Pharmaceuticals, is a passionate believer in the value of entrepreneurship and innovation. He began his entrepreneurial path with Niner Pharma, where he has over 16 years of experience in a variety of industries. Niner Pharma has a competitive advantage thanks to his insights into every facet of the market.
He is currently the CEO of JB Group of Companies (Singapore), JB Radiant Power Energy (Singapore), JB Medicare (Vietnam), JB ITES Solution (Dubai UAE), and JB Global Trade LLC (Dubai UAE). "Doing your best today is the best preparation for tomorrow," he advises. Don't sit around waiting for miracles to happen; go the additional mile and get things done." Mr. Balaji leads Niner Pharma with the goal of making it one of the top pharmaceutical firms in the world.
He has been honoured with prizes such as Africa's Best Entrepreneur of the Year Award, African Eagles Friends 2020's Best Investor and Entrepreneurs Award, the Government of Zimbabwe's Business Excellence Award, and the Nelson Mandela Peace Award 2021.
Niner Pharmaceuticals LLC, managed by a team of highly competent C-Level Executives, aspires to improve the lives of patients by identifying, developing, and commercialising significant solutions that meet unmet medical needs. The team's goal is to drive change through strategy creation and to pave a safe way to satisfy the needs of patients all around the world.
Niner Pharma intends to invest in Indian mid- and small-scale pharmaceutical companies, intermediate manufacturing companies, and API plants in order to expand their production capacity and gain acceptance in the global market. In addition, the business intends to have its manufacturing facilities in India certified by the USFDA, EU, and UK MHRA.